Healthy men help check if a Drug's new recipe works the same
NCT ID NCT07246291
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checks whether a new way of making the drug EnliTuo® works just like the old way. It involves 86 healthy male volunteers who get a single dose of either the new or old version. Researchers measure how the drug moves through the body, its safety, and whether it triggers an immune response.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- EnliTuo® (a biologic drug given as a single intravenous drip)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Xuhui Central Hospital
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple vest make breathing easier?
- Chilly workouts may alter what you eat, small study suggests
- New Parkinson's drug MF1 enters first human safety trial
- AI-Powered training cuts hamstring injury risk in pro footballers
- Beta-Alanine boost for cyclists? new study reveals mixed results
- New Egg-Maturing technique could help women with low IVF success